# Micronutrient Supplementation in Patients With Heart Failure

> **NCT01005303** · PHASE2,PHASE3 · COMPLETED · sponsor: **Belfast Health and Social Care Trust** · enrollment: 79 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Forceval plus 50 micrograms Vitamin D3

## Key facts

- **NCT ID:** NCT01005303
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-08
- **Final completion:** 2015-07
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005303, "Micronutrient Supplementation in Patients With Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01005303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*